Teplizumab in Relatives at Risk for Type 1 Diabetes. Reply
- PMID: 31693818
- DOI: 10.1056/NEJMc1912500
Teplizumab in Relatives at Risk for Type 1 Diabetes. Reply
Comment on
-
Teplizumab in Relatives at Risk for Type 1 Diabetes.N Engl J Med. 2019 Nov 7;381(19):1879. doi: 10.1056/NEJMc1912500. N Engl J Med. 2019. PMID: 31693815 No abstract available.
-
Teplizumab in Relatives at Risk for Type 1 Diabetes.N Engl J Med. 2019 Nov 7;381(19):1879. doi: 10.1056/NEJMc1912500. N Engl J Med. 2019. PMID: 31693816 No abstract available.
-
Teplizumab in Relatives at Risk for Type 1 Diabetes.N Engl J Med. 2019 Nov 7;381(19):1879-1880. doi: 10.1056/NEJMc1912500. N Engl J Med. 2019. PMID: 31693817 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical